Anionically modified polyallylamine derivative, use of anionically modified polyallylamine derivative as medicine, particularly for propylaxis and treatment of infections of respiratory tract caused by human metapneumovirus (hMPV), human rhinoviruses (HRV), and infection by influenza virus type A (IAV) and pharmaceutical composition comprising the anionically modified polyallylamine derivative
Номер патента: US09925215B1
Опубликовано: 27-03-2018
Автор(ы): Aleksandra MILEWSKA, Justyna CIEJKA, Krzysztof Pyrc, Krzysztof Szczubialka, Magdalena Wytrwal, Maria Nowakowska
Принадлежит: UNIWERSYTET JAGIELLONSKI
Получить PDF файл: Открыть в новом окне
Опубликовано: 27-03-2018
Автор(ы): Aleksandra MILEWSKA, Justyna CIEJKA, Krzysztof Pyrc, Krzysztof Szczubialka, Magdalena Wytrwal, Maria Nowakowska
Принадлежит: UNIWERSYTET JAGIELLONSKI
Получить PDF файл: Открыть в новом окне
Anionically modified n-sulfonic polyallylamine derivative, pharmaceutical composition comprising the n-sulfonic polyallylamine derivative as the active substance and use of said derivate for the production of a medicine
Номер патента: WO2016016820A3. Автор: Maria Nowakowska,Krzysztof Szczubialka,Krzysztof Pyrc,Justyna CIEJKA,Magdalena Wytrwal,Aleksandra MILEWSKA. Владелец: UNIWERSYTET JAGIELLONSKI. Дата публикации: 2016-10-13.